Workflow
达安基因: 第九届董事会2025年第二次临时会议决议公告

Group 1 - The company held its second temporary board meeting of 2025 on June 18, 2025, with all 9 board members present, and the meeting complied with relevant laws and regulations [1] - The board approved an adjustment to the company's organizational structure to enhance governance, asset management, and operational efficiency, including the establishment of new departments: Strategic Planning, Academic Promotion, and Asset Management, while renaming the Engineering Department to Safety Production and Property Management [2] - The board also approved the appointment of Yuan Yifan as the assistant to the general manager for a term of three years, aligning with the current board's term [2] Group 2 - Yuan Yifan has no shares in the company and has no relationships with other board members or significant shareholders, meeting all legal and regulatory requirements for the position [3] - His qualifications include a bachelor's degree from China Pharmaceutical University and previous roles in various biotechnology companies, indicating relevant experience for his new position [2][3]